Acrivon Therapeutics, Inc.
ACRV
$2.06
-$0.04-1.91%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -74.23M | -77.27M | -77.91M | -81.75M | -85.96M |
| Total Depreciation and Amortization | 1.50M | 1.43M | 1.36M | 1.30M | 1.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.79M | 14.25M | 15.31M | 14.88M | 13.44M |
| Change in Net Operating Assets | -2.98M | -3.08M | -2.43M | -212.00K | 486.00K |
| Cash from Operations | -62.92M | -64.67M | -63.67M | -65.79M | -70.83M |
| Capital Expenditure | -1.22M | -1.63M | -1.67M | -2.28M | -2.37M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 56.73M | 61.64M | 67.77M | 61.27M | 71.46M |
| Cash from Investing | 55.51M | 60.01M | 66.10M | 58.99M | 69.09M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.31M | 0.00 | 1.00K | 1.00K | 1.00K |
| Repurchase of Common Stock | -376.00K | -439.00K | -750.00K | -1.21M | -2.29M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.00K | -- | -- | 0.00 | -307.00K |
| Cash from Financing | 6.93M | -439.00K | -749.00K | -1.20M | -2.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -484.00K | -5.09M | 1.69M | -8.00M | -4.33M |